Fixed-dose formulations of rosuvastatin and ezetimibe loaded lipid-polymer hybrid nanoparticles were developed, employing a combination of polymer and lipid components designed to achieve a potential core-shell-like structure through nanoprecipitation method. ... ...

请注册登录后继续浏览